Search Results - Lixia Jiao
- Showing 1 - 2 results of 2
-
1
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl by Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Wenjun Fan, Nathan D. Wong, Katherine E. Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao, Deepak L. Bhatt, William S. Weintraub
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC by Benjamin E. Peterson, M.D, Deepak L. Bhatt, M.D., M.P.H, Ph.Gabriel Steg, M.D, Michael Miller, M.D, Eliot A. Brinton, M.D, Terry A. Jacobson, M.D, Steven B. Ketchum, Rebecca A. Juliano, Ph.D, Lixia Jiao, Ph.D, Ralph T. Doyle, Jr., B.A, Craig Granowitz, M.D., Ph.D, C. Michael Gibson, M.S., M.D, Duane Pinto, M.D, Robert P. Giugliano, M.D., S.M, Matthew J. Budoff, M.D, Jean-Claude Tardif, M.D, Subodh Verma, M.D., Ph.D, Christie M. Ballantyne, M.D
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book